Get the Stockscreener App
3.02
0.98%
-0.03
After Hours:
1.20
-1.82
-60.26%
Nephros Inc stock is traded at $3.02, with a volume of 9,696.
It is down -0.98% in the last 24 hours and down -24.88% over the past month.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.
See More
Previous Close:
$3.05
Open:
$3.0101
24h Volume:
9,696
Relative Volume:
0.19
Market Cap:
$32.15M
Revenue:
$18.79M
Net Income/Loss:
$1.19M
P/E Ratio:
27.33
EPS:
0.1105
Net Cash Flow:
$1.65M
1W Performance:
-1.15%
1M Performance:
-24.88%
6M Performance:
-27.75%
1Y Performance:
+96.10%
1-Day Range:
$3.0101
$3.21
1-Week Range:
$2.81
$3.21
52-Week Range:
$1.55
$6.42
Nephros Inc Stock (NEPH) Company Profile
Name
Nephros Inc
Sector
Industry
Phone
201.343.5202
Address
380 LACKAWANNA PLACE, SOUTH ORANGE, NJ
Compare NEPH vs PSNYW, SHMD, GOODO, DWLD, QQQE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 1.84 | 0 | 0 | 0 | 0 | 0.00 | |
PSNYW
Polestar Automotive Holding Uk
|
5.30 | 493.05M | 2.07B | -1.42B | -1.37B | -0.6765 |
SHMD
Schmid Group N V
|
7.42 | 364.76M | 52.15M | -21.46M | 0 | -0.4675 |
GOODO
Gladstone Commercial Corporation
|
19.92 | 372.90M | 0 | 0 | 0 | 0.00 |
DWLD
Davis Select Worldwide ETF
|
43.93 | 0 | 0 | 0 | 0 | 0.00 |
QQQE
Direxion NASDAQ-100 Equal Weigh
|
99.50 | 0 | 0 | 0 | 0 | 0.00 |
Nephros Inc Stock (NEPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-26-21 | Initiated | B. Riley Securities | Buy |
Nephros Inc Stock (NEPH) Latest News
Nephros (NASDAQ: NEPH) CEO exercises options for 120K shares - Stock Titan
Nephros (NEPH) CFO exercises stock options to acquire 68,861 common shares - Stock Titan
Q2 2025 Nephros Inc Earnings Call Transcript - GuruFocus
Q3 2025 Nephros Inc Earnings Call Transcript - GuruFocus
Portfolio Shifts: Will Nephros Inc stock hit new highs in YEAREarnings Recap Report & Precise Trade Entry Recommendations - baoquankhu1.vn
NEPH SEC FilingsNephros Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Aug Wrap: What is the cash position of Nephros Inc2026 Rallies & Entry Point Strategy Guides - baoquankhu1.vn
Gains Recap: Will Nephros Inc outperform during market ralliesDividend Hike & Entry Point Confirmation Alerts - baoquankhu1.vn
Hedge Fund Bets: Is Nephros Inc a stock for growth or value investors2026 Levels & Daily Chart Pattern Signals - baoquankhu1.vn
Trend Review: Does Nephros Inc offer margin of safetyTrend Reversal & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Retail Surge: Is Zions Bancorporation National Association a good stock for dollar cost averagingQuarterly Growth Report & Breakout Confirmation Alerts - baoquankhu1.vn
Director Arthur Amron receives 3,610 Nephros (NEPH) shares - Stock Titan
[Form 4] NEPHROS INC Insider Trading Ac... - Stock Titan
Benchmark reiterates Nephros stock Speculative Buy on Q4 beat - Investing.com
Stop Loss: Is Nephros Inc on track to beat earnings2026 Market Trends & Weekly Top Gainers Alerts - baoquankhu1.vn
Aug Patterns: Should I average down on Nephros Inc stock2026 Technical Patterns & Technical Entry and Exit Tips - baoquankhu1.vn
Downgrade Watch: Is Nephros Inc backed by strong institutional buying2026 Pullbacks & Intraday High Probability Alerts - baoquankhu1.vn
Nephros (NEPH) Q4 2025 Earnings Call Transcript - AOL.com
Nephros Earnings Call Highlights Growth Amid Tariffs - The Globe and Mail
Nephros, Inc. Forms Death Cross, Signaling Potential Bearish Trend Ahead - Markets Mojo
Buy Rating on Nephros Driven by Strong Revenue Momentum, Solid Balance Sheet, and Strategic Growth Upside Despite Margin Headwinds - TipRanks
Nephros, Inc. (NASDAQ:NEPH) Q4 2025 Earnings Call Transcript - Insider Monkey
Nephros Inc (NEPH) Q4 2025 Earnings Call Highlights: Strong Reve - GuruFocus
Nephros : Q4 / FY 2025 Conference Call Replay - marketscreener.com
Nephros, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Nephros Reports Record Revenue Growth and Second Consecutive Year of Profitability - citybuzz -
Nephros Inc (NASDAQ:NEPH) Reports Q4 2025 Revenue Beat and Record Annual Growth - ChartMill
NEPH: 33% revenue growth and second year of profitability, with strong recurring sales and cash position - TradingView
Earnings call transcript: Nephros beats Q4 2025 earnings expectations, stock dips - Investing.com
NEPHROS ($NEPH) Releases Q4 2025 Earnings - Quiver Quantitative
Nephros Inc reports results for the quarter ended December 31Earnings Summary - TradingView
--Nephros Announces Fourth Quarter and Record Fiscal Year 2025 Financial Results - Bitget
Water filtration provider Nephros' Q4 revenue rises on strong reorder activity - TradingView
Nephros, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Nephros (NASDAQ: NEPH) extends Medica deal and outlines major business risks - Stock Titan
Short Interest in Nephros Inc. (NASDAQ:NEPH) Drops By 57.8% - Defense World
Merger Talk: Is Nephros Inc a stock for growth or value investorsJuly 2025 Levels & Fast Moving Market Watchlists - baoquankhu1.vn
Shorts Report: Does Nephros Inc offer margin of safety2025 Market Sentiment & Growth Focused Stock Reports - baoquankhu1.vn
Nephros Schedules Fourth Quarter 2025 Financial Results Conference Call - Bitget
Nephros Schedules Fourth-Quarter 2025 Financial Results Conference Call for March 5, 2026 - geneonline.com
Nephros Inc expected to post earnings of 1 cent a shareEarnings Preview - TradingView
NEPH Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
NEPH Should I Buy - Intellectia AI
Gainers Report: What analysts say about Maiden Holdings Ltd stockJuly 2025 Trade Ideas & Scalable Portfolio Growth Ideas - baoquankhu1.vn
Nephros Enters New License Agreement with Medica - MSN
Nephros targets Puerto Rico with filtration solutions - News is My Business
Nephros expands into Puerto Rico with water filtration solutions By Investing.com - Investing.com Australia
Nephros expands into Puerto Rico with water filtration solutions - Investing.com South Africa
Nephros (NEPH) Expands Operations to Puerto Rico, Tapping into K - GuruFocus
Nephros Enters Puerto Rico Market with Focus on Water Safety in Healthcare and Hospitality - citybuzz -
Nephros, Inc. Expands into Puerto Rico to Deliver Differentiated Water Filtration Solutions Across Medical and Commercial Sectors - marketscreener.com
Nephros Inc Stock (NEPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.95%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):